Yan-Li Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yan-Li Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Wang
Department of Pharmacy, Suzhou Science and Technology Town Hospital, Suzhou, China
1 shared publication Ke-Ke Cao
Department of Quality management, Shenzhen Yuanxing gene-tech Co. Ltd , Shenzhen , China
1 shared publicationNai-Xin Kang
College of Pharmaceutical Science, Soochow University , Suzhou , China
1 shared publicationQiong-Ming Xu
College of Pharmaceutical Science, Soochow University , Suzhou , China
1 shared publicationShi-Liang Ji
Department of pharmacy, The Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University , Suzhou , China
1 shared publicationShi-Lin Yang
College of Pharmaceutical Science, Soochow University , Suzhou , China
1 shared publication
Latest Publications
- 4 July 2019
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 83 (11) , 2016-2026
Antioxidant activity of phenylethanoid glycosides on glutamate-induced neurotoxicity
Exposure of PC12 cells to 10 mM glutamate caused significant viability loss, cell apoptosis, decreased activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) as well as increased levels of malondialdehyde (MDA). In parallel, glutamate significantly increased the intracellular levels of ROS and intracellular calcium. However, pretreatment of the cells with acteoside and isoacteoside significantly suppressed glutamate-induced cellular events. Moreover, acteoside and isoacteoside reduced the glutamate-induced increase of caspase-3 activity and also ameliorated the glutamate-induced Bcl-2/Bax ratio reduction in PC12 cells. Furthermore, acteoside and isoacteoside significantly inhibited glutamate-induced DNA damage. In the mouse model, acteoside significantly attenuated cognitive deficits in the Y maze test and attenuated neuronal damage of the hippocampal CA1 regions induced by glutamate. These data indicated that acteoside and isoacteoside play neuroprotective effects through anti-oxidative stress, anti-apoptosis, and maintenance of steady intracellular calcium.
- 4 July 2019
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 83 (11) , 2016-2026
Antioxidant activity of phenylethanoid glycosides on glutamate-induced neurotoxicity
Exposure of PC12 cells to 10 mM glutamate caused significant viability loss, cell apoptosis, decreased activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) as well as increased levels of malondialdehyde (MDA). In parallel, glutamate significantly increased the intracellular levels of ROS and intracellular calcium. However, pretreatment of the cells with acteoside and isoacteoside significantly suppressed glutamate-induced cellular events. Moreover, acteoside and isoacteoside reduced the glutamate-induced increase of caspase-3 activity and also ameliorated the glutamate-induced Bcl-2/Bax ratio reduction in PC12 cells. Furthermore, acteoside and isoacteoside significantly inhibited glutamate-induced DNA damage. In the mouse model, acteoside significantly attenuated cognitive deficits in the Y maze test and attenuated neuronal damage of the hippocampal CA1 regions induced by glutamate. These data indicated that acteoside and isoacteoside play neuroprotective effects through anti-oxidative stress, anti-apoptosis, and maintenance of steady intracellular calcium.